<DOC>
	<DOCNO>NCT01240967</DOCNO>
	<brief_summary>The purpose study compare absorption distribution single oral dose TC-5214 subject renal impairment subject normal renal function .</brief_summary>
	<brief_title>To Compare Pharmacokinetics Single Oral Dose TC-5214 Subjects With Renal Impairment With Subjects With Normal Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Males nonpregnant , nonlactating female 18 80 year old inclusive suitable vein cannulation repeat venipuncture weight least 50 kg . Regarding renal function , subject classify either normal suffering mild , moderate severe renal impairment . Classification renal impairment base use abbreviated 4 variable Modified Diet Renal Disease ( MDRD ) equation . To ensure assessment consistent estimate glomerular filtration rate ( eGFR ) use MDRD , single equation use ( see Section 6.2 ) Negative screen Human Immunodeficiency Virus negative result serum hepatitis B surface antigen Regarding renal function , subject classify either normal suffering mild , moderate severe renal impairment . Classification renal impairment base use abbreviated 4 variable MDRD equation . To ensure assessment consistent estimate glomerular filtration rate ( eGFR ) use MDRD , single equation use . History clinically significant medical , neurologic psychiatric disease disorder ( previously define acceptable population ) , opinion Investigator sponsor , may either put subject risk participation study , influence result subject 's ability participate study : This include seizure activity repeat episode major depression . Subjects history suicide attempt past year and/or see Investigator significant history risk suicide homicide , consider risk suicide homicide study Subjects active renal transplant ( subject previously receive renal transplant currently undergoing dialysis due transplant failure may enrol ) Any clinically significant acute illness medical/surgical procedure within 4 week first administration investigational product ( IP ) ( previously define acceptable population ) judge Investigator . Positive test drug abuse screen ( except prescription medication , verify Investigator ) , alcohol admission clinic prior administration IP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>volunteer renal impairment</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>TC-5214</keyword>
</DOC>